Multipotent mesenchymal stromal cells (MSC) were administered to patients after allogeneic hematopoietic stem cell transplantation to prevent the development of acute graft—versus— host disease (GVHD). The injection of MSC did not always prevent the development of GVHD. The aim of the work was to compare the secretome of MSC effective and ineffective in the prevention of GVHD. MSC were obtained from the bone marrow of hematopoietic stem cells donors. The secretome was studied using a TripleTOF 5600+ mass spectrometer with a NanoSpray III ion source coupled to a NanoLC Ultra 2D Plus nano-HPLC System. A total of 1,965 proteins were analyzed. Analysis of the secretome of effective and ineffective MSC samples revealed significant differences in the secretion of 1,119 proteins associated with ribosomes, exosomes, focal contacts, and others. Analysis of proteins secreted by MSC can be used to identify prognostically effective samples.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ankrum JA, Ong JF, Karp JM. Mesenchymal stem cells: immune evasive, not immune privileged. Nat. Biotechnol. 2014;32(3):252-260. doi: https://doi.org/10.1038/nbt.2816
Bamberger AM, Jenatschke S, Schulte HM, Löning T, Bamberger MC. Leukemia inhibitory factor (LIF) stimulates the human HLA-G promoter in JEG3 choriocarcinoma cells. J. Clin. Endocrinol. Metab. 2000;85(10):3932- 3936. doi: https://doi.org/10.1210/jcem.85.10.6849
Charbonneau M, Lavoie RR, Lauzier A, Harper K, McDonald PP, Dubois CM. Platelet-derived growth factor receptor activation promotes the prodestructive invadosomeforming phenotype of synoviocytes from patients with rheumatoid arthritis. J. Immunol. 2016;196(8):3264-3275. doi: https://doi.org/10.4049/jimmunol.1500502
Chivukula RR, Shi G, Acharya A, Mills EW, Zeitels LR, Anandam JL, Abdelnaby AA, Balch GC, Mansour JC, Yopp A. C, Maitra A, Mendell JT. An essential mesenchymal function for miR-143/145 in intestinal epithelial regeneration. Cell. 2014;157(5):1104-1116. doi: https://doi.org/10.1016/j.cell.2014.03.055
Fastova EA, Magomedova AU, Petinati NA, Sats NV, Kapranov NM, Davydova YO, Drize NI, Kravchenko SK, Savchenko VG. Bone marrow multipotent mesenchymal stromal cells in patients with diffuse large B-cell lymphoma. Bull. Exp. Biol. Med. 2019;167(1):150-153. doi: https://doi.org/10.1007/s10517-019-04480-6
Foo JB, Looi QH, Chong PP, Hassan NH, Yeo GEC, Ng CY, Koh B, How CW, Lee SH, Law JX. Comparing the therapeutic potential of stem cells and their secretory products in regenerative medicine. Stem Cells Int. 2021;2021:2616807. doi: https://doi.org/10.1155/2021/2616807
Harrell CR, Fellabaum C, Jovicic N, Djonov V, Arsenijevic N, Volarevic V. Molecular mechanisms responsible for therapeutic potential of mesenchymal stem cell-derived secretome. Cells. 2019;8(5):467. doi: https://doi.org/10.3390/cells8050467
He X, Hong W, Yang J, Lei H, Lu T, He C, Bi Z, Pan X, Liu Y, Dai L, Wang W, Huang C, Deng H, Wei X. Spontaneous apoptosis of cells in therapeutic stem cell preparation exert immunomodulatory effects through release of phosphatidylserine. Signal Transduct. Target Ther. 2021;6(1):270. doi: https://doi.org/10.1038/s41392-021-00688-z
Hinden L, Shainer R, Almogi-Hazan O, Or R. Ex vivo induced regulatory human/murine mesenchymal stem cells as immune modulators. Stem Cells. 2015;33(7):2256-2267. doi: https://doi.org/10.1002/stem.2026
Ikuno Y, Kazlauskas A. TGFbeta1-dependent contraction of fibroblasts is mediated by the PDGFalpha receptor. Invest. Ophthalmol. Vis. Sci. 2002;43(1):41-46.
Kuzmina LA, Petinati NA, Parovichnikova EN, Lubimova LS, Gribanova EO, Gaponova TV, Shipounova IN, Zhironkina OA, Bigildeev AE, Svinareva DA, Drize NJ, Savchenko VG. Multipotent mesenchymal stromal cells for the prophylaxis of acute graft-versus-host disease — a phase II study. Stem Cells Int. 2012;2012:968213. doi: https://doi.org/10.1155/2012/968213
Li X, Bai J, Ji X, Li R, Xuan Y, Wang Y. Comprehensive characterization of four different populations of human mesenchymal stem cells as regards their immune properties, proliferation and differentiation. Int. J. Mol. Med. 2014;34(3):695-704. doi: https://doi.org/10.3892/ijmm.2014.1821
Lindholm CK, Frantz JD, Shoelson SE, Welsh M. Shf, a Shb-like adapter protein, is involved in PDGF-alpha- receptor regulation of apoptosis. Biochem. Biophys. Res. Commun. 2000;278(3):537-543. doi: https://doi.org/10.1006/bbrc.2000.3847
Mushahary D, Spittler A, Kasper C, Weber V, Charwat V. Isolation, cultivation, and characterization of human mesenchymal stem cells. Cytometry A. 2018;93(1):19-31. doi: https://doi.org/10.1002/cyto.a.23242
Vizoso FJ, Eiro N, Cid S, Schneider J, Perez-Fernandez R. Mesenchymal stem cell secretome: toward cell-free therapeutic strategies in regenerative medicine. Int. J. Mol. Sci. 2017;18(9):1852. doi: https://doi.org/10.3390/ijms18091852
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Kletochnye Tekhnologii v Biologii i Meditsine, No. 1, pp. 19-23, March, 2022
Rights and permissions
About this article
Cite this article
Petinati, N.A., Drize, N.I., Arapidi, G.P. et al. Differences in Protein Secretion by Multipotent Mesenchymal Stromal Cells Effective and Ineffective in the Prevention of Acute Graft—Versus—Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation. Bull Exp Biol Med 173, 128–132 (2022). https://doi.org/10.1007/s10517-022-05507-1
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-022-05507-1